Health BeOne Secures $885 Million Upfront in Royalty Financing Agreement BeOne Medicines, formerly known as BeiGene, has entered into a significant royalty financing agreement, securing an upfront payment of $885 million linked to Amgen’s... Editorial19 hours ago